Hit enter to search or ESC to close
Inceptua GroupInceptua GroupInceptua GroupInceptua Group
  • About
    • History
    • Mission
    • Quality
    • Leadership
    • Careers
  • Comparator Sourcing &
    Clinical Trial Services
  • Pre-approval &
    Unlicensed Medicines Access
    • For companies seeking support for access to their medicines
    • For physicians seeking access to unlicensed medicines
  • Inceptua
    Pharma
    • Jetrea®(ocriplasmin)
    • Farydak®(panobinostat)
  • News
    • Insights
    • News and Press Releases
  • Contact
    • General contacts
    • Partnering request
    • Medicines access requests
    • Safety and product complaints
    • Inceptua Pharma Access to Medicines Policy
  • IMAP Medicines Access Portal
  • 日本語
    All Posts By

    Mark Corbett

    Medicines AccessWhite Paper

    Providing Access to Unlicensed Medicines

    What’s driving demand for unlicensed medicines in non-launch or non-com-mercialised markets? And what are the challenges for the pharmaceutical manufacturer of not actively engaging in providing access? Irrespective of the manufacturers stance,…
    Mark Corbett
    Mark CorbettMarch 14, 2019
    Medicines AccessThought leadership

    What life science companies need to know about pre-approval access

    Pre-approval access is evolving at a rapid pace. Mark Corbett, Executive Vice President of Medicines Access at Inceptua, gives you an overview of the key benefits of utilizing pre-approval access…
    Mark Corbett
    Mark CorbettOctober 9, 2018

    © 2021 Inceptua Group.
    Contact | Privacy policy | Terms of use | Cookie policy
    Anti-slavery and Human trafficking statement | Company information

    • About
      • History
      • Mission
      • Quality
      • Leadership
      • Careers
    • Comparator Sourcing &
      Clinical Trial Services
    • Pre-approval &
      Unlicensed Medicines Access
      • For companies seeking support for access to their medicines
      • For physicians seeking access to unlicensed medicines
    • Inceptua
      Pharma
      • Jetrea®(ocriplasmin)
      • Farydak®(panobinostat)
    • News
      • Insights
      • News and Press Releases
    • Contact
      • General contacts
      • Partnering request
      • Medicines access requests
      • Safety and product complaints
      • Inceptua Pharma Access to Medicines Policy
    • IMAP Medicines Access Portal
    • 日本語